Funded Tech Companies

Sidewinder Therapeutics

Sidewinder Therapeutics, operating out of Sacramento, received equity investments through Astellas Venture Capital, Alexandria Venture Investments and Novartis Venture Fund.

Company Overview

Contact Information

Company Background Information

Overview

Sidewinder Therapeutics is pioneering the next generation of bispecific antibody-drug conjugates. We aim to deliver next-generation bispecific antibody-drug conjugates (ADCs) that expand the therapeutic window for patients with difficult to treat cancers. Built by a dynamic team of serial entrepreneurs, expert scientists and drug developers, we are advancing bispecific ADCs engineered to target receptor co-complexes that are highly expressed on certain solid tumors with enhanced tumor cell specificity and internalization.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

4/8/2026

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Eric Murphy

        

Co-Founder

Ryan Corcoran

        

President

Rob McRae

        

VP - General Counsel

Michael Mueller

        

Company Investors

• Astellas Venture Capital
• Alexandria Venture Investments
• Novartis Venture Fund (Michal Silverberg)
• OrbiMed
• Longwood Fund
• Frazier Life Sciences (Daniel Estes)
• Samsara BioCapital
• DCVC Bio (John Hamer)
• Goldman Sachs (Josh Richardson)

Browse more funded tech companies:

Sidewalk Infrastructure Partners | Sidework

Share this article

About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary